UNSPSC 85724308: Revision of nonautologous tissue substitute in right sacroiliac joint, external approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of nonautologous tissue substitute in right sacroiliac joint, external approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0SW7XKZ

UNSPSC 85724308, Revision of nonautologous tissue substitute in right sacroiliac joint, external approach, a Commodity code, shows no relevant recent state and local procurement activity. The six opportunities posted between July and September 2026 in the most-recent-opportunities block are tagged to this code but span independent medical evaluations for public safety pension disability determinations, surgical benefit carve-out programs for municipal employees, occupational medical surveillance for ferry workers, emergency and specialty medical services for detained youth, pharmacy benefit management, and temporary health professional staffing—none of which involve tissue substitutes, orthopedic implants, or sacroiliac joint procedures. The mismatch between the code's clinical scope and the actual work being solicited suggests either systematic miscoding at issuing jurisdictions or an error in code assignment; the code does not reflect active procurement of the product or service it nominally describes.

The geographic spread and issuing-body mix evident in the opportunities block—Arizona (City of Phoenix), California (City of Long Beach, County of Santa Clara), Washington (WSDOT), Florida (Collier County), and Texas (Harris County)—reflect state and local healthcare administration, benefits management, and occupational health demand across counties, cities, and state transportation agencies, but none connect to the orthopedic surgical or implant product domain. Business development professionals should verify whether this code is appropriately indexed for tissue-substitute or joint-procedure procurements in their target markets before allocating pursuit resources; current activity under the code does not support a relevant buying pattern.